Recent discussions on X about Astera Labs (ALAB) have centered around the company's impressive financial performance and its role in the AI infrastructure space. Many users have highlighted the company's latest quarterly results, noting a significant revenue increase and earnings growth that surpassed expectations. The buzz reflects a growing interest in how Astera Labs is positioning itself as a key player in semiconductor connectivity solutions for AI and cloud computing.
Additionally, there’s notable excitement on X regarding upcoming events, such as the company’s participation in major financial conferences scheduled for late August and early September 2025. Posts on the platform suggest that investors are keenly watching for further updates on strategic partnerships and product developments. The tone of these conversations underscores a strong curiosity about the stock’s potential trajectory in the rapidly evolving tech landscape.
Note: This discussion summary was generated from an AI condensation of post data.
Astera Labs Congressional Stock Trading
Members of Congress have traded $ALAB stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ALAB stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 02/27.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Astera Labs Insider Trading Activity
Astera Labs insiders have traded $ALAB stock on the open market 216 times in the past 6 months. Of those trades, 0 have been purchases and 216 have been sales.
Here’s a breakdown of recent trading of $ALAB stock by insiders over the last 6 months:
- SANJAY GAJENDRA (President and COO) has made 0 purchases and 39 sales selling 1,122,778 shares for an estimated $133,198,080.
- JITENDRA MOHAN (Chief Executive Officer) has made 0 purchases and 83 sales selling 1,082,778 shares for an estimated $119,527,107.
- MICHAEL TRUETT TATE (Chief Financial Officer) has made 0 purchases and 20 sales selling 853,768 shares for an estimated $96,040,470.
- MANUEL ALBA has made 0 purchases and 48 sales selling 228,000 shares for an estimated $18,148,006.
- STEFAN A DYCKERHOFF has made 0 purchases and 8 sales selling 52,000 shares for an estimated $9,065,696.
- PHILIP MAZZARA (General Counsel and Secretary) has made 0 purchases and 11 sales selling 86,046 shares for an estimated $8,299,589.
- MICHAEL E. HURLSTON has made 0 purchases and 4 sales selling 2,500 shares for an estimated $228,906.
- BETHANY MAYER has made 0 purchases and 3 sales selling 686 shares for an estimated $60,003.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Astera Labs Hedge Fund Activity
We have seen 366 institutional investors add shares of Astera Labs stock to their portfolio, and 216 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ATREIDES MANAGEMENT, LP removed 3,697,481 shares (-79.5%) from their portfolio in Q2 2025, for an estimated $334,326,232
- VANGUARD GROUP INC added 2,751,747 shares (+29.6%) to their portfolio in Q2 2025, for an estimated $248,812,963
- BLACKROCK, INC. added 2,471,597 shares (+53.1%) to their portfolio in Q2 2025, for an estimated $223,481,800
- ALLIANCEBERNSTEIN L.P. removed 2,009,439 shares (-23.9%) from their portfolio in Q2 2025, for an estimated $181,693,474
- JENNISON ASSOCIATES LLC removed 1,736,440 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $103,613,374
- INVESCO LTD. removed 1,399,341 shares (-74.4%) from their portfolio in Q2 2025, for an estimated $126,528,413
- D. E. SHAW & CO., INC. removed 1,345,848 shares (-39.9%) from their portfolio in Q2 2025, for an estimated $121,691,576
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Astera Labs Analyst Ratings
Wall Street analysts have issued reports on $ALAB in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 08/07/2025
- Morgan Stanley issued a "Overweight" rating on 08/06/2025
- Stifel issued a "Buy" rating on 08/04/2025
- Jefferies issued a "Buy" rating on 07/22/2025
- William Blair issued a "Outperform" rating on 05/22/2025
- Evercore ISI Group issued a "Outperform" rating on 05/21/2025
- Needham issued a "Buy" rating on 05/07/2025
To track analyst ratings and price targets for Astera Labs, check out Quiver Quantitative's $ALAB forecast page.
Astera Labs Price Targets
Multiple analysts have issued price targets for $ALAB recently. We have seen 10 analysts offer price targets for $ALAB in the last 6 months, with a median target of $137.5.
Here are some recent targets:
- Tom O'Malley from Barclays set a target price of $155.0 on 08/07/2025
- Mehdi Hosseini from Susquehanna set a target price of $125.0 on 08/07/2025
- Joseph Moore from Morgan Stanley set a target price of $155.0 on 08/06/2025
- N. Quinn Bolton from Needham set a target price of $170.0 on 08/06/2025
- Mark Lipacis from Evercore ISI Group set a target price of $215.0 on 08/06/2025
- Tore Svanberg from Stifel set a target price of $145.0 on 08/04/2025
- Blayne Curtis from Jefferies set a target price of $130.0 on 07/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
